Autoimmunity in CD73/Ecto-5'-nucleotidase deficient mice induces renal injury. 2012

Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
Division of Nephrology, Department of Medicine, Hannover Medical School, Hannover, Germany. Blume.cornelia@mh-hannover.de

Extracellular adenosine formed by 5'-ectonucleotidase (CD73) is involved in tubulo-glomerular feedback in the kidney but is also known to be an important immune modulator. Since CD73(-/-)mutant mice exhibit a vascular proinflammatory phenotype, we asked whether long term lack of CD73 causes inflammation related kidney pathologies. CD73(-/-)mice (13 weeks old) showed significantly increased low molecule proteinuria compared to C57BL6 wild type controls (4.8 ≥ 0.52 vs. 2.9 ± 0.54 mg/24 h, p<0.03). Total proteinuria increased to 5.97 ± 0.78 vs. 2.55 ± 0.35 mg/24 h at 30 weeks (p<0.01) whereas creatinine clearance decreased (0.161 ± 0.02 vs. 0.224 ± 0.02 ml/min). We observed autoimmune inflammation in CD73(-/-)mice with glomerulitis and peritubular capillaritis, showing glomerular deposition of IgG and C3 and enhanced presence of CD11b, CD8, CD25 as well as GR-1-positive cells in the interstitium. Vascular inflammation was associated with enhanced serum levels of the cytokines IL-18 and TNF-α as well as VEGF and the chemokine MIP-2 (CXCL-2) in CD73(-/-)mice, whereas chemokines and cytokines in the kidney tissue were unaltered or reduced. In CD73(-/-)mice glomeruli, we found a reduced number of podocytes and endothelial fenestrations, increased capillaries per glomeruli, endotheliosis and enhanced tubular fibrosis. Our results show that adult CD73(-/-)mice exhibit spontaneous proteinuria and renal functional deterioration even without exogenous stress factors. We have identified an autoimmune inflammatory phenotype comprising the glomerular endothelium, leading to glomeruli inflammation and injury and to a cellular infiltrate of the renal interstitium. Thus, long term lack of CD73 reduced renal function and is associated with autoimmune inflammation.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
November 2008, Pflugers Archiv : European journal of physiology,
Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
September 2004, The Journal of clinical investigation,
Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
March 2007, Journal of the American Society of Nephrology : JASN,
Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
July 2013, Kidney international,
Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
October 2011, Journal of immunology (Baltimore, Md. : 1950),
Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
June 2006, Purinergic signalling,
Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
November 2020, ACS medicinal chemistry letters,
Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
June 2013, Clinical & experimental metastasis,
Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
January 2020, Frontiers in pharmacology,
Cornelia Blume, and Agnieszka Felix, and Nelli Shushakova, and Faikah Gueler, and Christine Susanne Falk, and Hermann Haller, and Juergen Schrader
January 2013, Cardiovascular research,
Copied contents to your clipboard!